Published in Clin Oral Investig on December 30, 2016
Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol (2008) 2.32
Definition and prevalence of peri-implant diseases. J Clin Periodontol (2008) 2.01
Smoking interferes with the prognosis of dental implant treatment: a systematic review and meta-analysis. J Clin Periodontol (2007) 1.99
Periimplant diseases: where are we now?--Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol (2011) 1.84
Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review. Eur J Oral Implantol (2012) 1.62
Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol (2008) 1.56
Systematic review and meta-analysis of the effect of various laser wavelengths in the treatment of peri-implantitis. J Periodontol (2014) 1.50
Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol (1997) 1.41
Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol (2008) 1.32
Role of osteopontin in neutrophil function. Immunology (2007) 1.25
Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol (2013) 1.25
Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol (2008) 1.18
Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res (2002) 1.17
The frequency of peri-implant diseases: a systematic review and meta-analysis. J Periodontol (2012) 1.08
Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg (2010) 1.08
Enamel matrix proteins; old molecules for new applications. Orthod Craniofac Res (2009) 1.03
Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine (2010) 1.02
Non-surgical treatment of peri-implantitis using an air-abrasive device or mechanical debridement and local application of chlorhexidine: a prospective, randomized, controlled clinical study. J Clin Periodontol (2011) 1.02
Consensus statements and recommended clinical procedures regarding implant survival and complications. Int J Oral Maxillofac Implants (2004) 1.01
Clinical research on peri-implant diseases: consensus report of Working Group 4. J Clin Periodontol (2012) 1.01
A proposed classification for peri-implantitis. Int J Periodontics Restorative Dent (2012) 1.00
Impact of implant overloading on the peri-implant bone in inflamed and non-inflamed peri-implant mucosa. Clin Oral Implants Res (2007) 0.99
A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol (2001) 0.98
Is keratinized mucosa indispensable to maintain peri-implant health? A systematic review of the literature. J Biomed Mater Res B Appl Biomater (2013) 0.96
Periodontitis as a potential risk factor for peri-implantitis. J Clin Periodontol (2009) 0.95
Mechanical non-surgical treatment of peri-implantitis: a double-blind randomized longitudinal clinical study. I: clinical results. J Clin Periodontol (2009) 0.95
Clinical evaluation of an Er:YAG laser for nonsurgical treatment of peri-implantitis: a pilot study. Clin Oral Implants Res (2005) 0.95
Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial. J Periodontol (2008) 0.93
Successful management of peri-implantitis with a regenerative approach: a consecutive series of 51 treated implants with 3- to 7.5-year follow-up. Int J Periodontics Restorative Dent (2012) 0.92
Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review. J Periodontol (2011) 0.91
Adjunctive local antibiotic therapy in the treatment of peri-implantitis II: clinical and radiographic outcomes. Clin Oral Implants Res (2007) 0.90
Stimulation of osteoblasts with Emdogain increases the expression of specific mineralization markers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 0.90
The role of cell surface markers and enamel matrix derivatives on human periodontal ligament mesenchymal progenitor responses in vitro. Biomaterials (2011) 0.89
Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro. J Clin Periodontol (2002) 0.89
Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: six-month outcomes of a prospective randomized clinical trial. Clin Oral Implants Res (2012) 0.89
The efficacy of interventions to treat peri-implantitis: a Cochrane systematic review of randomised controlled clinical trials. Eur J Oral Implantol (2008) 0.88
Nonsurgical antimicrobial photodynamic therapy in moderate vs severe peri-implant defects: a clinical pilot study. Quintessence Int (2013) 0.87
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review. Eur J Oral Implantol (2009) 0.87
Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol (2002) 0.86
Peri-implantitis. Br J Oral Maxillofac Surg (2011) 0.86
Enamel matrix proteins and systemic antibiotics as adjuncts to non-surgical periodontal treatment: clinical effects. J Clin Periodontol (2005) 0.86
Effect of Emdogain on proliferation and migration of different periodontal tissue-associated cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.85
Managing peri-implant bone loss: current understanding. Clin Implant Dent Relat Res (2011) 0.83
Antibiotics in the treatment of peri-implantitis. Eur J Oral Implantol (2012) 0.83
Decontamination of dental implant surface in peri-implantitis treatment: a literature review. Med Oral Patol Oral Cir Bucal (2013) 0.83
IL-17 gene polymorphism is associated with chronic periodontitis and peri-implantitis in Iranian patients: a cross-sectional study. Immunol Invest (2013) 0.83
Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol (2011) 0.83
The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis. J Am Dent Assoc (2012) 0.83
Clinical outcome of a nonsurgical and surgical treatment protocol in different types of peri-implantitis: a case series. Quintessence Int (2013) 0.82
Periodontitis vs. peri-implantitis: the same disease? The same treatment? Crit Rev Oral Biol Med (1996) 0.81
Evaluation of enamel matrix derivative as an adjunct to non-surgical periodontal therapy. J Clin Periodontol (2003) 0.81
Cytokine and matrix metalloproteinase expression in fibroblasts from peri-implantitis lesions in response to viable Porphyromonas gingivalis. J Periodontal Res (2013) 0.80
Emdogain regulation of cellular differentiation in wounded rat periodontium. J Periodontal Res (2003) 0.79
Moderate effect of enamel matrix derivative (Emdogain Gel) on Porphyromonas gingivalis growth in vitro. Arch Oral Biol (2005) 0.79
Peri-implant mucositis treatments in humans: a systematic review. Ann Stomatol (Roma) (2012) 0.79
Effects of enamel matrix derivative on gene expression of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 0.79
Effects of enamel matrix derivative on the viability, cytokine secretion, and phagocytic activity of human monocytes. J Endod (2010) 0.79
Healing after standardized clinical probing of the perlimplant soft tissue seal: a histomorphometric study in dogs. Clin Oral Implants Res (2002) 0.79
Histologic evaluation of human intrabony defects following non-surgical periodontal therapy with and without application of an enamel matrix protein derivative. J Periodontol (2003) 0.79
Peri-implant disease and chronic periodontitis: is interleukin-6 gene promoter polymorphism the common risk factor in a Brazilian population? Int J Oral Maxillofac Implants (2013) 0.78
Prognosis in implant dentistry: a system for classifying the degree of peri-implant mucosal inflammation. J Can Dent Assoc (2011) 0.77
Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts. Arch Oral Biol (2009) 0.76
The impact of genotypes and immune reactivity on peri-implant inflammation: Identification and therapeutic use of anti-inflammatory drugs and immunomodulators. Eur J Oral Implantol (2012) 0.76